Back to top
more

Delcath Systems (DCTH)

(Delayed Data from NSDQ)

$16.34 USD

16.34
491,047

-0.05 (-0.31%)

Updated Aug 28, 2026 04:00 PM ET

After-Market: $16.33 -0.01 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 248)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates

by Zacks Equity Research

Delcath Systems (DCTH) delivered earnings and revenue surprises of -70% and 9.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Waters (WAT) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Waters (WAT) delivered earnings and revenue surprises of 1.35% and 1.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Delcath Systems (DCTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High?

by Zacks Equity Research

The mean of analysts' price targets for Delcath Systems (DCTH) points to a 58.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Atyr Pharma (ATYR) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.

Zacks Equity Research

Delcath Systems, Inc. (DCTH) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Delcath Systems (DCTH) delivered earnings and revenue surprises of 150% and 33.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Corcept Therapeutics (CORT) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Corcept Therapeutics (CORT) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.

Zacks Equity Research

Agilent Q1 Earnings Beat Estimates, Stock Falls on Cautious FY25 View

by Zacks Equity Research

A's first-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.

Zacks Equity Research

Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength

by Zacks Equity Research

Delcath Systems (DCTH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. (DCTH) is a Great Choice

by Zacks Equity Research

Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.